Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children

Vaccine ◽  
2004 ◽  
Vol 22 ◽  
pp. S49-S54 ◽  
Author(s):  
Thea K. Fischer ◽  
Joseph S. Bresee ◽  
Roger I. Glass
2006 ◽  
Vol 134 (5) ◽  
pp. 908-916 ◽  

Rotaviruses are a major cause of hospitalizations for acute gastroenteritis in developed countries. This review shows the burden of rotavirus disease in <5-year-old children in Europe. An estimated 72000–77000 hospitalizations for community-acquired rotavirus disease occur annually in the 23 million under-fives living in the European Union (EU-25), with a median cost of €1417 per case. Annual hospitalization incidence rates range from 0·3 to 11·9/1000 children <5 years old (median 3/1000). The median proportion of hospital-acquired rotavirus disease among all cases of hospitalization for rotavirus disease is estimated to be 21%. Countries of the EU-25 require information on the burden of rotavirus disease to support introduction of rotavirus vaccines. Data on cases treated at home, medical visits, and emergency wards as well as rotavirus-associated deaths are limited. To fully evaluate the impact and effectiveness of rotavirus vaccination programmes in Europe, additional epidemiological studies will be critical and desirable.


2008 ◽  
Vol 42 (7) ◽  
pp. 1-9
Author(s):  
MIRIAM E. TUCKER
Keyword(s):  

2005 ◽  
Vol 35 (20) ◽  
pp. 2
Author(s):  
NANCY WALSH
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document